-
Food for the Final Four
Tweet Share on Facebook April 4, 2008 Comment (1)All the Cinderella teams have been squashed in this year's NCAA tournament, leaving us with four No. 1-seeded powerhouses in the Final Four. CBS's ratings for the games are down, and some sportswriters have groused that March Madness is downright boring this year.
Still, come this weekend, millions of us will be settling down in front of the tube for the Final Four with our buddies, beer, and some cheese-drenched slices of Domino's. Maybe we'll wolf down some wings, or a sub, too, for good measure. We know eating junk food is a nightmare for our health and guts, but it's pretty much an unwritten and mandatory rule that as men we must heap on the fast food when we watch sports.
-
On Circumcision Debate, Studies Cut Both Ways
Tweet Share on Facebook April 2, 2008 Comment (18)A New Zealand study published in the Journal of Pediatrics adds yet another wrinkle to the acrimonious debate over circumcision. The study found that circumcision doesn't appear to protect men living in the developed world from certain sexually transmitted diseases, Reuters reports. Researchers at the University of Otago found that of 499 men they have followed since the 1970s, the same percentage of circumcised men and uncircumcised men—about 23 percent—developed bacterial and viral STDs such as chlamydia, genital warts, and herpes. The researchers didn't collect data on HIV, which is comparatively rare in New Zealand.
Most news in the last few years about circumcision has been dominated by the results of three randomized trials in African countries that found the procedure considerably reduces a man's risk of contracting HIV. In one of the studies, the risk was reduced by as much as 76 percent. Since then, public-health officials in some African countries have been scrambling to develop large-scale circumcision programs. The implications for Americans, however, remain murky. There are differences between the African and North American HIV epidemics, and the CDC has emphasized that benefits seen in the African trials don't necessarily translate to America.













